Insider Transactions
Showing insider trading activity for Khan Najat.
Insider Trading Activity Chart
Visualizing insider transactions on stock price candles
Transaction Type
Insider Role
Min Transaction Value
No stock price data available.
Recent Filings
| Symbol | Name | Filed | Transaction | Type | Role | Shares |
|---|---|---|---|---|---|---|
| RXRX | Khan Najat | 19 May 2026 | 15 May 2026 | F-InKind | director, officer: CEO and President | 62,701 |
| RXRX | Khan Najat | 11 Mar 2026 | 9 Mar 2026 | S-Sale | director, officer: CEO and President | 28,298 |
| RXRX | Khan Najat | 19 Feb 2026 | 17 Feb 2026 | F-InKind | director, officer: CEO and President | 14,280 |
| RXRX | Khan Najat | 10 Feb 2026 | 6 Feb 2026 | A-Award | director, officer: CEO and President | 1,673,546 |
| RXRX | Khan Najat | 10 Feb 2026 | 6 Feb 2026 | A-Award | director, officer: CEO and President | 30,346 |
| RXRX | Khan Najat | 10 Feb 2026 | 6 Feb 2026 | F-InKind | director, officer: CEO and President | 10,364 |
| RXRX | Khan Najat | 29 Dec 2025 | 22 Dec 2025 | S-Sale | director, officer: Chief R&D Commercial Officer | 124,403 |
| RXRX | Khan Najat | 19 Nov 2025 | 17 Nov 2025 | F-InKind | director, officer: Chief R&D Commercial Officer | 17,584 |
| RXRX | Khan Najat | 6 Nov 2025 | 5 Nov 2025 | A-Award | director, officer: Chief R&D Commercial Officer | 84,925 |
| RXRX | Khan Najat | 6 Nov 2025 | 5 Nov 2025 | A-Award | director, officer: Chief R&D Commercial Officer | 169,851 |
| RXRX | Khan Najat | 19 Aug 2025 | 15 Aug 2025 | F-InKind | director, officer: Chief R&D Commercial Officer | 3,789 |
| RXRX | Khan Najat | 19 Aug 2025 | 18 Aug 2025 | S-Sale | director, officer: Chief R&D Commercial Officer | 36,599 |